Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 21 Apr 2025 for Paragon 28, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Meghan Scanlon: trading record in brief
This profile gathers the share dealings of Meghan Scanlon across 2 companies, led by Boston Scientific Corp and Paragon 28, Inc. Between 1 May 2021 and 21 April 2025, the trades on record add up to 13 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 21 April 2025 with a transaction in Paragon 28, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Meghan Scanlon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
42,113 sharesCommon StockSEC:0000950170-25-056369:0
15,906 shares0Common StockSEC:0001610717-24-000251:0
8,361 shares0Common StockSEC:0001610717-23-000056:0
2,062 shares0Common StockSEC:0001225208-22-006331:0
17,846 shares0Common StockSEC:0001567619-22-008111:0
1,019 shares0Common StockSEC:0001225208-22-003868:0
779 shares0Common StockSEC:0001225208-22-003088:0
1,583 shares0Common StockSEC:0001225208-22-002933:0
1,108 shares0Common StockSEC:0001225208-22-002699:0
13,850 shares@ US$23.4153.5% of flowCommon StockSEC:0001225208-21-010901:0
855 shares0Common StockSEC:0001225208-21-010279:0
16,450 shares@ US$17.2646.5% of flowCommon StockSEC:0001225208-21-009606:0
2,061 shares0Common StockSEC:0001225208-21-007475:0
13 of 13 declarations
